BioCentury

1:33 AM GMT, Oct 16, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Abbott adds $4.3B on HCV data

Abbott Laboratories (NYSE:ABT) added $4.3 billion in market cap on Monday after reporting data from the Phase

Read the full 178 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.